• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

In Case You Missed It - 2016 Study Compared Hepatitis C Treatment Costs

January 3, 2017
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Summary: 
A study, “Comparison of Hepatitis C Treatment Costs, Estimates of Net Prices and Usage in the U.S. and Other Major Markets,” was published by the IMS Institute for Healthcare Informatics.
image of the comparison of HCV treatment costs report cover

In September, the IMS Institute for Healthcare Informatics published a study, Comparison of Hepatitis C Treatment Costs, Estimates of Net Prices and Usage in the U.S. and Other Major Markets. The study measured the estimated total hepatitis C treatment costs in the United States compared with prices in six European countries and Japan. In the United States, total cost was further broken down by the percent paid by Medicare Part D plans. The study also measured how many of those with HCV had been treated in each country. This study is one of the first to describe and compare the cost and utilization of hepatitis C therapies since the approval of new, highly effective direct acting agents became available in 2013.

Read the full report here.

This study was conducted independently by the IMS Institute with funding support from the Pharmaceutical Care Management Association (PCMA).
 

2016 study on #HepC treatment costs compared US and other countries spending: http://go.usa.gov/x94Q8

TWEET THIS

 

Posted In: 
Prevention and Wellness
Medicare and Medicaid
Tagged: Hepatitis C